The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Enhanced clearance of HIV-1–infected cells by broadly neutralizing antibodies against HIV-1 in vivo
Open accessAbstract
Insights into antibody therapy for HIV-1: Despite the success of antiretroviral therapy, HIV-1-infected individuals still harbor latent virus. Thus, other therapeutic strategies are needed. A single injection of a broad and potent monoclonal antibody targeting the HIV-1 envelope protein reduced viral loads in HIV-1-infected individuals, albeit only transiently. Lu et al. now report that antibody treatment not only blocked free virus from infecting new cells, it also accelerated the clearance of infected cells. Furthermore, Schoofs et al. demonstrate that therapeutic antibody treatment enhanced infected individuals' humoral response against the virus. Thus, neutralizing antibodies may be a promising therapy for HIV-1 because of their potential to reduce the viral reservoir. Science , this issue pp. 1001 and 997
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gibaldi, M., & Perrier, D. (1982) · CRC Press eBooks · doi:10.1201/b14095 · Cited by 4,093
Decay characteristics of HIV-1-infected compartments during combination therapy
Perelson, A. S., Essunger, P., Cao, Y., Vesanen, M., Hurley, A., Saksela, K., Markowitz, M., & Ho, D. D. (1997) · Nature · doi:10.1038/387188a0 · Cited by 1,880
Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
Haynes, B. F., Gilbert, P. B., McElrath, M. J., Zolla-Pazner, S., Tomaras, G. D., Alam, S. M., Evans, D. T., Montefiori, D. C., Karnasuta, C., Sutthent, R., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113425 · Cited by 1,808
Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target
Walker, L. M., Phogat, S. K., Chan-Hui, P.-Y., Wagner, D., Phung, P., Goss, J. L., Wrin, T., Simek, M. D., Fling, S., Mitcham, J. L., et al. (2009) · Science · doi:10.1126/science.1178746 · Cited by 1,723
Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection
Doitsh, G., Galloway, N. L. K., Geng, X., Yang, Z., Monroe, K. M., Zepeda, O., Hunt, P. W., Hatano, H., Sowinski, S., Muñoz-Arias, I., et al. (2014) · Nature · doi:10.1038/nature12940 · Cited by 1,179
Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding
Scheid, J. F., Mouquet, H., Ueberheide, B., Diskin, R., Klein, F., Oliveira, T. Y. K., Pietzsch, J., Fenyo, D., Abadir, A., Velinzon, K., et al. (2011) · Science · doi:10.1126/science.1207227 · Cited by 1,139
Self-citationFc receptor but not complement binding is important in antibody protection against HIV
Hessell, A. J., Hangartner, L., Hunter, M., Havenith, C. E. G., Beurskens, F. J., Bakker, J. M., Lanigan, C. M. S., Landucci, G., Forthal, D. N., Parren, P. W. H. I., et al. (2007) · Nature · doi:10.1038/nature06106 · Cited by 901
Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117
Caskey, M., Klein, F., Lorenzi, J. C. C., Seaman, M. S., West, A. P., Buckley, N., Kremer, G., Nogueira, L., Braunschweig, M., Scheid, J. F., et al. (2015) · Nature · doi:10.1038/nature14411 · Cited by 767
Self-citationHuman Immunodeficiency Virus Type 1 Spinoculation Enhances Infection through Virus Binding
O'Doherty, U., Swiggard, W. J., & Malim, M. H. (2000) · Journal of Virology · doi:10.1128/jvi.74.21.10074-10080.2000 · Cited by 664
Quantitative Image Analysis of HIV-1 Infection in Lymphoid Tissue
Haase, A. T., Henry, K., Zupancic, M., Sedgewick, G., Faust, R. A., Melroe, H., Cavert, W., Gebhard, K., Staskus, K., Zhang, Z.-Q., et al. (1996) · Science · doi:10.1126/science.274.5289.985 · Cited by 599
Complex-type N -glycan recognition by potent broadly neutralizing HIV antibodies
Mouquet, H., Scharf, L., Euler, Z., Liu, Y., Eden, C., Scheid, J. F., Halper-Stromberg, A., Gnanapragasam, P. N. P., Spencer, D. I. R., Seaman, M. S., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1217207109 · Cited by 550
Self-citationFätkenheuer, G., Pozniak, A. L., Johnson, M. A., Plettenberg, A., Staszewski, S., Hoepelman, A. I. M., Saag, M. S., Goebel, F. D., Rockstroh, J. K., Dezube, B. J., et al. (2005) · Nature Medicine · doi:10.1038/nm1319 · Cited by 495
Broadly Neutralizing Anti-HIV-1 Antibodies Require Fc Effector Functions for In Vivo Activity
Bournazos, S., Klein, F., Pietzsch, J., Seaman, M. S., Nussenzweig, M. C., & Ravetch, J. V. (2014) · Cell · doi:10.1016/j.cell.2014.08.023 · Cited by 493
Self-citationThe Role of Antibodies in HIV Vaccines
Mascola, J. R., & Montefiori, D. C. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101256 · Cited by 388
Halper-Stromberg, A., Lu, C.-L., Klein, F., Horwitz, J. A., Bournazos, S., Nogueira, L., Eisenreich, T. R., Liu, C., Gazumyan, A., Schaefer, U., et al. (2014) · Cell · doi:10.1016/j.cell.2014.07.043 · Cited by 381
Self-citationStructural Insights on the Role of Antibodies in HIV-1 Vaccine and Therapy
West, A. P., Scharf, L., Scheid, J. F., Klein, F., Bjorkman, P. J., & Nussenzweig, M. C. (2014) · Cell · doi:10.1016/j.cell.2014.01.052 · Cited by 321
Self-citationMouse model recapitulating human Fcγ receptor structural and functional diversity
Smith, P., DiLillo, D. J., Bournazos, S., Li, F., & Ravetch, J. V. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1203954109 · Cited by 307
Self-citationHorwitz, J. A., Halper-Stromberg, A., Mouquet, H., Gitlin, A. D., Tretiakova, A., Eisenreich, T. R., Malbec, M., Gravemann, S., Billerbeck, E., Dorner, M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1315295110 · Cited by 271
Self-citationThe role of Fc–FcγR interactions in IgG-mediated microbial neutralization
Bournazos, S., DiLillo, D. J., & Ravetch, J. V. (2015) · The Journal of Experimental Medicine · doi:10.1084/jem.20151267 · Cited by 175
Self-citationIgarashi, T., Brown, C., Azadegan, A., Haigwood, N., Dimitrov, D., Martin, M. A., & Shibata, R. (1999) · Nature Medicine · doi:10.1038/5576 · Cited by 164
Antibody B cell responses in HIV-1 infection
Mouquet, H. (2014) · Trends in Immunology · doi:10.1016/j.it.2014.08.007 · Cited by 141
Quantitative Image Analysis of HIV-1 Infection in Lymphoid TissuePreprint
Haase, A. T., Henry, K., Zupancic, M., Sedgewick, G., Faust, R. A., Melroe, H., Cavert, W. P., Gebhard, K. H., Staskus, K., Zhang, Z., et al. (1996) · RePEc: Research Papers in Economics · Cited by 127
A requirement for FcγR in antibody-mediated bacterial toxin neutralization
Abboud, N., Chow, S.-K., Saylor, C., Markmann, A. J., Ravetch, J. V., Scharff, M. D., & Casadevall, A. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20100995 · Cited by 109
Self-citationCurrent Estimates for HIV-1 Production Imply Rapid Viral Clearance in Lymphoid Tissues
de Boer, R. J., Ribeiro, R. M., & Perelson, A. S. (2010) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000906 · Cited by 95
Pollara, J., Bonsignori, M., Moody, M. A., Pazgier, M., Haynes, B. F., & Ferrari, G. (2013) · Current HIV Research · doi:10.2174/1570162x113116660059 · Cited by 87
Pietzsch, J., Gruell, H., Bournazos, S., Donovan, B. M., Klein, F., Diskin, R., Seaman, M. S., Björkman, P. J., Ravetch, J. V., Ploß, A., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1213409109 · Cited by 82
Self-citationWhich Antibody Functions are Important for an HIV Vaccine?
Su, B., & Moog, C. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00289 · Cited by 68
Role of F c‐mediated antibody function in protective immunity against HIV ‐1
Lewis, G. K. (2013) · Immunology · doi:10.1111/imm.12232 · Cited by 66
Joos, B., Trkola, A., Kuster, H., Aceto, L., Fischer, M., Stiegler, G. M., Armbruster, C., Vcelar, B. A., Katinger, H. W. D., & Günthard, H. F. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.5.1773-1779.2006 · Cited by 64
HIV-specific antibody immunity mediated through NK cells and monocytes.
Kramski, M., Parsons, M. S., Stratov, I., & Kent, S. (2013) · Current HIV Research · doi:10.2174/1570162x113116660061 · Cited by 54
The role of Fc receptors in HIV prevention and therapy
Boesch, A. W., Brown, E. P., & Ackerman, M. E. (2015) · Immunological Reviews · doi:10.1111/imr.12339 · Cited by 47
Exploring the Potential of Monoclonal Antibody Therapeutics for HIV-1 Eradication
Euler, Z., & Alter, G. (2014) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2014.0235 · Cited by 46
Kramski, M., Stratov, I., & Kent, S. J. (2014) · AIDS · doi:10.1097/qad.0000000000000523 · Cited by 38
Müller, V., Marée, A. F. M., & de Boer, R. J. (2001) · Journal of Virology · doi:10.1128/jvi.75.6.2597-2603.2001 · Cited by 25
Pretransplant Immune-Regulation Predicts Allograft Tolerance
Dutta, P., Dart, M. L., Roenneburg, D. A., Torrealba, J. R., & Burlingham, W. J. (2011) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03484.x · Cited by 23
A simple method for identifying parameter correlations in partially observed linear dynamic models
Li, P., & Vu, Q. D. (2015) · BMC Systems Biology · doi:10.1186/s12918-015-0234-3 · Cited by 11
Cited by
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
Shen, C., Wang, Z., Zhao, F., Yang, Y., Li, J., Yuan, J., Wang, F., Li, D., Yang, M., Xing, L., et al. (2020) · JAMA · doi:10.1001/jama.2020.4783 · Cited by 2,277
Convalescent plasma as a potential therapy for COVID-19
Chen, L., Xiong, J., Bao, L., & Shi, Y. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30141-9 · Cited by 1,038
Beyond binding: antibody effector functions in infectious diseases
Lu, L. L., Suscovich, T. J., Fortune, S. M., & Alter, G. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.106 · Cited by 825
The role of IgG Fc receptors in antibody-dependent enhancement
Bournazos, S., Gupta, A., & Ravetch, J. V. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-00410-0 · Cited by 617
Self-citationCombination therapy with anti-HIV-1 antibodies maintains viral suppression
Mendoza, P., Gruell, H., Nogueira, L., Pai, J. A., Butler, A. L., Millard, K., Lehmann, C., Suárez, I., Oliveira, T. Y., Lorenzi, J. C. C., et al. (2018) · Nature · doi:10.1038/s41586-018-0531-2 · Cited by 521
Self-citation
Metadata
- Authors
- Lu, C.-L., Murakowski, D. K., Bournazos, S., Schoofs, T., Sarkar, D., Halper-Stromberg, A., Horwitz, J. A., Nogueira, L., Golijanin, J., Gazumyan, A., Ravetch, J. V., Caskey, M., Chakraborty, A. K., & Nussenzweig, M. C.
- Venue
- Science
- Published
- 2016-05-20
- Volume
- 352
- Issue
- 6288
- Pages
- 1001-1004
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2347047438
- Cited by
- 347
- References
- 36
- FWCI
- 30.93
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.